Stock data
TriSalus Life Sciences, Inc. (TLSI)
TriSalus Life Sciences, Inc. (TLSI) reported revenue of US$45.15M and net income of -US$39.23M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$45.15M | US$38.19M | -US$26.95M | -US$39.23M | — |
| 2024 | US$29.43M | US$25.33M | -US$36.16M | -US$30.05M | — |
| 2023 | US$18.51M | US$15.91M | -US$54.48M | -US$59.36M | — |
| 2022 | US$12.40M | US$10.14M | -US$36.44M | -US$47.19M | — |
| 2021 | — | — | -US$3.04M | US$4.77M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$11.41M | -US$9.19M | — |
| 2026-03-31 | US$8.90M | US$1.54M | — |
| 2025-12-31 | US$13.21M | -US$9.75M | — |
| 2025-09-30 | US$11.57M | -US$10.81M | — |
| 2025-06-30 | US$11.21M | -US$8.29M | — |
| 2025-03-31 | US$9.17M | -US$10.38M | — |
| 2024-12-31 | US$8.26M | -US$10.11M | — |
| 2024-09-30 | US$7.35M | -US$2.40M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.